Autodesk to present at upcoming investor conferences

Autodesk, Inc.(NASDAQ: ADSK) today announced its executives will be speaking at the following investor conferences: December 2, 2025 UBS Global Technology and AI Conference December 10, 2025 Barclays 23rd Annual Global Technology Conference https://mma.prnewswire.com/media/1686356/Autodesk_Black_Logo.jpg A live webcast and replay of the presentations will be available through Autodesk's Investor Relations Website atinvestors.autodesk.com. Please go to the […]

Women Business Collaborative Announces Four Distinguished Leaders Joining Its Board of Directors

Women Business Collaborative (WBC), the unprecedented alliance dedicated to accelerating equal position, pay, and power for all women in business, is proud to announce the appointment of four exceptional leaders to its Board of Directors: Nicola Bates, President and CEO, Siemens Capital Company; Denella Clark, President & CEO of the Boston Arts Academy Foundation; Dawn

Fannie Mae Releases October 2025 Monthly Summary

Fannie Mae's (OTCQB: FNMA) October 2025 Monthly Summary is now available. The monthly summary report contains information about Fannie Mae's monthly and year-to-date activities for our gross mortgage portfolio, mortgage-backed securities and other guarantees, interest rate risk measures, and serious delinquency rates. https://mma.prnewswire.com/media/1608392/Fannie_Mae_Logo.jpg Follow Fannie Maefanniemae.comOn X: @FannieMae Fannie Mae Newsroomhttps://www.fanniemae.com/newsroom Photo of Fannie Maehttps://www.fanniemae.com/resources/img/about-fm/fm-building.tif

Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg

— If approved, investigational semaglutide 7.2 mg injection would offer the optionality of a higher dose for greater weight loss potential in adults with obesity1,2 — In the STEP UP phase 3 trial, adults with obesity taking semaglutide 7.2 mg as directed lost an average of 20.7% body weight2,3* — The supplemental New Drug Application

Blue Owl Capital Inc. to Present at the Goldman Sachs 2025 US Financial Services Conference

Blue Owl Capital Inc. (NYSE: OWL) (“Blue Owl”) today announced that DougOstrover, co-CEO, will present at the Goldman Sachs 2025 US Financial Services Conference on Wednesday, December 10, 2025 at 1:40 pm ET. A webcast of the presentation will be broadcast live on the Shareholders section of Blue Owl's website at www.ir.blueowl.com. For those unable

The Epstein Law Firm Urges Drivers to Stay Alert During Thanksgiving Return Travel

With millions of Americans already on the road for the Thanksgiving holiday, The Epstein Law Firm is urging New Jersey drivers to stay vigilant during the high-risk travel period that continues through the weekend. https://mma.prnewswire.com/media/2746246/The_Epstein_Law_Firm_PA_Logo.jpg Michael J. Epstein, Managing Director of The Epstein Law Firm, P.A., warned that the most dangerous traffic patterns occur not

Asiacell announces partnership with Google Cloud to bring AI-powered productivity tools, including Google Workspace, to Iraq

Asiacell, a leading telecommunications company in Iraq, today announced a partnership with Google Cloud to deliver Google Workspace and other AI-powered collaboration tools to businesses and educational institutions across Iraq. https://mma.prnewswire.com/media/2832732/Google_Cloud_and_Asiacell.jpg This collaboration positions Asiacell as the first telecom operator in Iraq to offer Google Cloud's productivity and collaboration solutions, supporting the country's growing digital

SECTRA LAUNCHES ITS BUILT-IN REPORTING SOLUTION IN THE US–ACCELERATES DIAGNOSTICS FOR IMPROVED PATIENT CARE

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) is introducing its built-in reporting solution for medical imaging, Sectra Reporting, to the US market. By unifying image review and reporting together in the diagnostic workflow, radiologists can work in a single application and avoid switching between systems. This shortens turnaround times, reduces workload,

mAIbe and LenioBio announce a new strategic collaboration aimed at accelerating the discovery and experimental validation of next-generation monoclonal antibodies

mAIbe and LenioBio are pleased to announce a new strategic collaboration aimed at accelerating the discovery and experimental validation of next-generation monoclonal antibodies. https://mma.prnewswire.com/media/2735875/LenioBio_Logo.jpg By combining mAIbe's AI-driven platform for antibody design and optimizationwithLenioBio's cell-free expression technology, this partnership brings together two complementary strengths to significantly enhance thedesign-build-test cycle. LenioBio's ultrafast, scalable expression system enables

The new PMO Collection for Jira is available, centralizing project governance and decision-making

A new set of Atlassian Marketplace apps for Jira is helping the PMO to standardize projects and report for everyone involved in the project lifecycle. EnterprisePMOs (Project Management Offices) still answer strategic questions by chasing data across disconnected tools. The PMO Collection for Jira has arrived to consolidate project portfolios in different views and reports,

Scroll to Top